bis(1,4)-diphosphoinositol tetrakisphosphate has been researched along with isoproterenol in 1 studies
| Studies (bis(1,4)-diphosphoinositol tetrakisphosphate) | Trials (bis(1,4)-diphosphoinositol tetrakisphosphate) | Recent Studies (post-2010) (bis(1,4)-diphosphoinositol tetrakisphosphate) | Studies (isoproterenol) | Trials (isoproterenol) | Recent Studies (post-2010) (isoproterenol) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 30,780 | 803 | 2,640 |
| Protein | Taxonomy | bis(1,4)-diphosphoinositol tetrakisphosphate (IC50) | isoproterenol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.246 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.333 | |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.77 | |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 0.6667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Safrany, ST; Shears, SB | 1 |
1 other study(ies) available for bis(1,4)-diphosphoinositol tetrakisphosphate and isoproterenol
| Article | Year |
|---|---|
Turnover of bis-diphosphoinositol tetrakisphosphate in a smooth muscle cell line is regulated by beta2-adrenergic receptors through a cAMP-mediated, A-kinase-independent mechanism.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Bradykinin; Cell Line; Cricetinae; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Inositol Phosphates; Isoproterenol; Male; Mesocricetus; Muscle, Smooth; Phosphodiesterase Inhibitors; Phosphorylation; Receptors, Adrenergic, beta-2; Sodium Fluoride; Type C Phospholipases; Vas Deferens | 1998 |